Strategic Drug Positioning: Best Practices, LLC Report Reveals Key Strategies for Product Launches

CHAPEL HILL, N.C., Jan. 10, 2025/ -- In the fast-paced world of biopharmaceuticals, executing the new product planning framework is crucial to avoid costly missteps and ensure long-term market success.

Best Practices, LLC has released a comprehensive benchmarking study titled "Strategic Portfolio Planning for Successful New Product and Drug Platform Positioning," which provides in-depth insights into the factors that contribute to product portfolio management excellence.

Drawing on data from 22 benchmark analyses and case studies, including successes like Sovaldi and lessons from Exubera’s pitfalls, the report offers actionable strategies to optimize launch plans and avoid common pitfalls.

According to the study:

• Creating alliances with patient advocacy groups and building relationships with key patient advocates are rated as the most important disease awareness activities.
• Salesforce size and training, salesforce effectiveness, and customer targeting offer significant cost-saving opportunities for organizations.

The report’s focus areas include:

• Key success factors for executing a flawless pharma launch
• Pitfalls to avoid for streamlined execution
• Trends in planning, resources, and digital influence
• Strategic portfolio platforms
• Novel tech / MOA market development

For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw427.htm

Pressed for time? A short video summary of the key insights is available to provide an overview of the report's main recommendations: